The Canadian Journal of Oncology
Overview
The Canadian Journal of Oncology is a scientific journal, published since 1991 in English. The journal's country of origin is Canada and its primary focus area is oncology.
Details
Recent Articles
11.
Dixon P
Can J Oncol
. 1996 Feb;
6 Suppl 1:74-83; discussion 84.
PMID: 8853542
We have prospectively gathered information contained in the Ontario Cancer Foundation computerized clinical data base to provide a quantitative description of palliative radiotherapy workload and fractionation practices in the management...
12.
Priestman T
Can J Oncol
. 1996 Feb;
6 Suppl 1:69-73; discussion 84.
PMID: 8853541
A number of different palliative radiotherapy techniques and fractionation schedules have been used in the UK over the past several years. In an attempt to standardize treatment practices, a handful...
13.
Coia L
Can J Oncol
. 1996 Feb;
6 Suppl 1:62-8; discussion 84.
PMID: 8853540
In fact that radiation therapy is often the most effective means of palliating symptoms caused by cancer is well recognized in the United States. Estimates of the proportion of patients...
14.
Hodson D, Bruera E, Eapen L, Groome P, Keane T, Larsson S, et al.
Can J Oncol
. 1996 Feb;
6 Suppl 1:54-60.
PMID: 8853539
The role of radiotherapy in the palliation of patients with advanced cancer of the head and neck is not clear. Several distinctive characteristics of advanced head and neck cancer contribute...
15.
Paszat L, Shenouda G, Blood P, Nolan M, Pater J, Whelan T
Can J Oncol
. 1996 Feb;
6 Suppl 1:48-53.
PMID: 8853538
Brain metastases (BRM) are common complications of malignancy, frequently associated with disability and death. Clinical trials have addressed a few of the issues arising from treatment options for BRM. Phase...
16.
Wong R, Thomas G, Cummings B, Froud P, Shelley W, Withers R, et al.
Can J Oncol
. 1996 Feb;
6 Suppl 1:39-47.
PMID: 8853537
Unresectable pelvic recurrence from carcinoma of the rectum becomes invariably symptomatic. While radiotherapy remains the most common antineoplastic modality used for palliation of symptoms, the optimal radiation dose and fractionation...
17.
Kirkbride P, Mackillop W, Priestman T, Browman G, Gospodarowicz M, Rousseau P
Can J Oncol
. 1996 Feb;
6 Suppl 1:33-8.
PMID: 8853536
Painful bone metastases are a clear indication for the use of radiotherapy, with reported response rates of up to 85% of patients treated. In an attempt to define the optimal...
18.
Brundage M, Bezjak A, Dixon P, Grimard L, Larochelle M, Warde P, et al.
Can J Oncol
. 1996 Feb;
6 Suppl 1:25-32.
PMID: 8853535
Non-small cell lung cancer is the most common cause of cancer death in both males and females. Despite this high incidence and mortality, comparatively little research has addressed the palliative...
19.
Priestman T
Can J Oncol
. 1996 Feb;
6 Suppl 1:17-22.
PMID: 8853534
A significant number of cancer patients undergoing palliative radiotherapy experience treatment-related nausea and vomiting. A number of factors are known to influence the incidence and severity of radiation-induced sickness including...
20.
Withers H
Can J Oncol
. 1996 Feb;
6 Suppl 1:12-6.
PMID: 8853533
There is a dearth of knowledge on the radiobiology of palliative radiotherapy, but some of the principles relevant to radical radiation treatments can be applied to the palliative situation. Nevertheless...